O46.02 Antepartum hemorrhage with disseminated intravascular coagulation

Name of the Condition

• Antepartum Hemorrhage with Disseminated Intravascular Coagulation
• O46.02

Summary

Antepartum hemorrhage refers to bleeding from the genital tract during pregnancy, typically after 20 weeks of gestation. When associated with disseminated intravascular coagulation (DIC), the condition involves abnormal blood clotting throughout the body’s small blood vessels, which can exacerbate bleeding and complicate management. DIC may arise from severe obstetric complications or systemic issues, requiring prompt evaluation and intervention.

Causes

The causes of antepartum hemorrhage with DIC often include obstetric complications such as placental abruption, placenta previa, or uterine rupture. DIC can also be triggered by severe infections, trauma, or conditions leading to systemic inflammation, which disrupt normal clotting mechanisms and promote widespread clot formation and subsequent bleeding.

Risk Factors

• Placental abruption or previa
• Severe infection or sepsis
• Trauma or abdominal injury
• Preexisting clotting disorders
• Multiple pregnancies
• Hypertension or preeclampsia
• Use of anticoagulant medications

Symptoms

• Vaginal bleeding (ranging from spotting to heavy flow)
• Abdominal pain or cramping
• Signs of DIC, such as bruising, prolonged bleeding from minor injuries, or petechiae
• Rapid heart rate or low blood pressure in severe cases
• Fatigue or weakness due to blood loss

Diagnosis

Diagnosis involves assessing the bleeding pattern and evaluating coagulation status through blood tests, including complete blood count, coagulation screening, and fibrinogen levels. Imaging studies like ultrasound may be used to identify obstetric causes of hemorrhage. Monitoring for signs of organ dysfunction or shock is also critical.

Treatment Options

• Stabilization of the mother’s condition with intravenous fluids and blood products
• Addressing the underlying cause of hemorrhage (e.g., delivery for placental abruption)
• Managing DIC with supportive care, such as platelet transfusions or antifibrinolytic agents
• Close monitoring of maternal and fetal status

Prognosis and Follow-Up

Prognosis depends on the severity of hemorrhage and DIC, as well as the timeliness of treatment. Complications may include organ damage or maternal mortality if not managed promptly. Follow-up care involves monitoring for recurrent bleeding, coagulation abnormalities, and obstetric complications in subsequent pregnancies.

Complications

• Severe blood loss leading to shock
• Organ failure due to impaired blood flow
• Maternal or fetal mortality
• Long-term coagulation disorders

Lifestyle & Prevention

• Prenatal care to monitor for high-risk conditions
• Avoiding trauma or injury during pregnancy
• Managing preexisting clotting disorders or hypertension
• Prompt treatment of infections or obstetric complications

When to Seek Professional Help

Seek immediate medical attention for heavy vaginal bleeding, severe abdominal pain, signs of shock (e.g., dizziness, rapid heartbeat), or uncontrolled bleeding from minor injuries.

Tips for Medical Coders

Document the presence of DIC and its relationship to antepartum hemorrhage clearly. Include details on the underlying cause of hemorrhage (e.g., placental abruption) and any associated complications to support accurate coding. Ensure documentation aligns with clinical findings and guidelines for O46.02.